Novocure (NVCR) Misses Q4 EPS by 25c

Novocure (NASDAQ: NVCR) reported Q4 EPS of ($0.61), $0.25 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $161.26 million versus the consensus estimate of $153.04 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ
• Genco Shipping & Trading Limited (GNK) 8400 contracts of August 30 calls trade, share price up 5.5%
• Wealthfront launches custodial account with tax-gain harvesting